Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Urinary Bladder Neoplasms 2Urinary Tract Infections 1Tissue Adhesions 1Stomach Neoplasms 1Polyps 1Non-Muscle Invasive Bladder Neoplasms 1Neutropenia 1Neoplasms 1Myoma 1Multiple Myeloma 1Infections 1Hematologic Neoplasms 1Hearing Loss 1Febrile Neutropenia 1Endometritis 1Ear Neoplasms 1Drug-Related Side Effects and Adverse Reactions 1Cystitis 1

Interventions

Terlipressin 4Sodium Chloride 4Vasopressins 3Uterine Myomectomy 3Uterine Artery Embolization 3carbetocin 2testo 1relugolix 1Ultrasonography 1Tourniquets 1Saline Solution 1Radiofrequency Ablation 1Oxytocin 1Ofloxacin 1MoxDuo 1Misoprostol 1Magnesium Sulfate 1Hysteroscopy 1Ethamsylate 1Embolization, Therapeutic 1Doxycycline 1Bupivacaine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Myoma × Ofloxacin × Clear all
NCT00830401 2015-06-04

The Impact of Treating Minor Uterine Cavity Abnormalities Diagnosed by Office Hysteroscopy in Unselected In Vitro Fertilization (IVF) Cases

UMC Utrecht

Phase 2 Terminated
700 enrolled

Tissue Adhesions, Endometritis, Myoma, Polyps

Data powered by HemOnc (CC BY 4.0) Colophon âš¡